NEDD9 gene polymorphism influences the risk of Alzheimer disease and cognitive function in Chinese older persons

Alzheimer Disease and Associated Disorders

Volumn 26, Issue 1, 2012, Pages 88-90

  Fu, Yan ^a   He, Fang ^a,b,c   Tang, Nelson Leung Sang ^a   Tam, Cindy Woon Chi ^a   Lui, Victor Wing Cheong ^a   Chiu, Helen Fung Kum ^a   Lam, Linda Chiu Wa ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

^c CUHK Joint Laboratory of Bio resources and Molecular Research in Common Diseases   (China)

Author keywords

Alzheimer disease; cognitive function; developmentally downregulated gene; gene polymorphisms; neural precursor cell expressed

Indexed keywords

APOLIPOPROTEIN E4; CELL PROTEIN; NEURAL PRECURSOR CELL EXPRESSED DEVELOPMENTALLY DOWNREGULATED 9 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHINESE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GERIATRIC PATIENT; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COGNITION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PHOSPHOPROTEINS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84857793121     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e3182135ef3     Document Type: Article

References (10)

1. Li Y, Grupe A, Rowland C, et al. Evidence that common variation in NEDD9 is associated with susceptibility to lateonset Alzheimer's and Parkinson's disease. Hum Mol Genet. 2008;17:759-767. (Pubitemid 351292264)
2. Chapuis J, Moisan F, Mellick G, et al. Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's disease. Hum Mol Genet. 2008;17:2863-2867.
3. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944. (Pubitemid 14076461)
4. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
5. Chu LW, Chiu KC, Hui SL, et al. The reliability and validity of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) among the elderly Chinese in Hong Kong. Ann Acad Med Singapore. 2000;29:474-485.
6. Mok EH, Lam LC, Chiu HF. Category verbal fluency test performance in chinese elderly with Alzheimer's disease. Dement Geriatr Cogn Disord. 2004;18:120-124. (Pubitemid 39140360)
7. Ma SL, Tang NL, Lam LC, et al. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease. Neurobiol Aging. 2005;26:1005-1010. (Pubitemid 40312663)
8. Li YJ, Scott WK, Hedges DJ, et al. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet. 2002;70:985-993. (Pubitemid 34259314)
9. Sasaki T, Iwata S, Okano HJ, et al. Nedd9 protein, a Cas-L homologue, is upregulated after transient global ischemia in rats: possible involvement of Nedd9 in the differentiation of neurons after ischemia. Stroke. 2005;36:2457-2462. (Pubitemid 41566977)
10. Knutson DC, Clagett-Dame M. atRA Regulation of NEDD9, a gene involved in neurite outgrowth and cell adhesion. Arch Biochem Biophys. 2008;477:163-174.